158 related articles for article (PubMed ID: 21896622)
1. Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.
Sarfati J; Bachelot A; Coussieu C; Meduri G; Touraine P;
Eur J Endocrinol; 2011 Nov; 165(5):779-88. PubMed ID: 21896622
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal androgen-secreting ovarian tumors: challenging differential diagnosis in two cases.
Arteaga E; Martinez A; Jaramilo J; Villaseca P; Cuello M; Valenzuela P; Gejman R; Blumel JE
Climacteric; 2019 Aug; 22(4):324-328. PubMed ID: 30623686
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
4. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry.
Sharma A; Kapoor E; Singh RJ; Chang AY; Erickson D
Clin Chem; 2018 Nov; 64(11):1636-1645. PubMed ID: 30068692
[TBL] [Abstract][Full Text] [Related]
6. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
[TBL] [Abstract][Full Text] [Related]
7. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
8. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
Kaltsas GA; Isidori AM; Kola BP; Skelly RH; Chew SL; Jenkins PJ; Monson JP; Grossman AB; Besser GM
J Clin Endocrinol Metab; 2003 Jun; 88(6):2634-43. PubMed ID: 12788867
[TBL] [Abstract][Full Text] [Related]
9. No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours.
Pelusi C; Forlani G; Zanotti L; Gambineri A; Pasquali R
Clin Endocrinol (Oxf); 2013 Apr; 78(4):533-8. PubMed ID: 22583337
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal androgen secreting ovarian tumour: pathophysiological implications; a case report.
Pérez A; Calaf J; Webb SM; Prat J; de Leiva A
Eur J Obstet Gynecol Reprod Biol; 1990 Apr; 35(1):97-105. PubMed ID: 2107106
[TBL] [Abstract][Full Text] [Related]
11. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
Zhou WB; Chen N; Li CJ
BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
[TBL] [Abstract][Full Text] [Related]
12. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
[TBL] [Abstract][Full Text] [Related]
13. Androgen-Secreting Ovarian Tumors.
Macut D; Ilić D; Mitrović Jovanović A; Bjekić-Macut J
Front Horm Res; 2019; 53():100-107. PubMed ID: 31499493
[TBL] [Abstract][Full Text] [Related]
14. Hyperandrogenism in post-menopausal women: a diagnosis challenge.
Tutzer M; Winnykamien I; Davila Guardia J; Castelo-Branco C
Gynecol Endocrinol; 2014 Jan; 30(1):23-5. PubMed ID: 24188447
[TBL] [Abstract][Full Text] [Related]
15. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
Palha A; Cortez L; Tavares AP; Agapito A
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
[TBL] [Abstract][Full Text] [Related]
16. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
17. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
19. Ovarian steroid cell tumor as an example of severe hyperandrogenism in 45-year-old woman.
Szeliga A; Zysnarska A; Podfigurna A; Maciejewska-Jeske M; Moszyński R; Sajdak S; Jasiński P; Frankowski A; Genazzani AR; Męczekalski B
Gynecol Endocrinol; 2020 Apr; 36(4):303-307. PubMed ID: 31718336
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic strategy in infertility due to hyperandrogenism. Development of a decision tree].
Cordray JP; Merceron RE; Siboulet B; Guillerd X; Nys P; Reboul P; Rainaut M
Rev Fr Gynecol Obstet; 1994 May; 89(5):245-54. PubMed ID: 8036386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
